Financhill
Back

Intra-Cellular Therapies Stock Predictions

Intra-Cellular Therapies Stock Forecast

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 40.8% based on the past 10 years of stock performance.
  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Intra-Cellular Therapies Stock Undervalued?
    The current Intra-Cellular Therapies [ITCI] share price is $78.20. The Score for ITCI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 40.8% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell
47
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com

52-Week Data

52-Week High:
84.89
52-Week Low:
45.50

Prediction Charts

Market Cap:
8.26B
Price in USD:
78.20
Volume:
1.06M
Beta:
1.07

Technical Analysis

SMA50:
70.47
SMA100:
69.71
SMA200:
66.12
52-Wk Change:
25.97%

Stock Predictions

  • Is Intra-Cellular Therapies stock public?
    Yes, Intra-Cellular Therapies is a publicly traded company.
  • What is the Intra-Cellular Therapies stock quote today?
    The Intra-Cellular Therapies stock price is 78.20 USD today.
  • How to buy Intra-Cellular Therapies stock online?
    You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-3 67.81 69.07 69.13 67.68
Jul-5 69.00 69.56 69.72 68.16
Jul-8 69.53 71.56 71.72 68.98
Jul-9 71.68 74.07 74.36 71.25
Jul-10 75.14 77.29 77.56 74.54
Jul-11 77.40 78.36 79.71 77.21
Jul-12 78.31 78.12 79.03 77.48
Jul-15 78.10 78.72 79.03 77.57
Jul-16 79.26 78.57 79.88 78.46
Jul-17 77.90 76.58 78.62 75.94
Jul-18 76.53 74.94 76.83 74.45
Jul-19 75.24 74.86 76.10 74.48
Jul-22 75.75 76.48 76.55 74.62
Jul-23 76.48 78.20 79.38 75.59

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.57 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.